Episode Details

Intuitive Surgical’s stock is plummeting—down 30% this year, its worst performance since 2008—despite strong procedure and revenue growth. Investors are spooked by lower-than-expected full-year projections and rising competition from J&J and Medtronic. Though still trading at a premium valuation, the stock could keep falling, matching or surpassing last year’s 26% drop. Yet with massive potential in robotic surgery, some see this as a long-term buying opportunity—if you can wait it out.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/4b77a54b1cbdd736